← Back to catalogue

Orthocord

FDA UDI

Class II (US FDA UDI)

by Medos International Sàrl

Identity

Trade Name
ORTHOCORD FDA UDI
Generic Name
Polyester suture, bioabsorbable, monofilament, non-antimicrobial FDA UDI
Device Name
ORTHOCORD Violet Braided Composite Suture BB 17 mm 3/8c, Taper Point N=1 Meets U.S.P. and E.P. except for diameter 3-0 (2 metric), 18 Inches (45 cm) FDA UDI
Model / Reference
223125 FDA UDI
Description
ORTHOCORD Violet Braided Composite Suture BB 17 mm 3/8c, Taper Point N=1 Meets U.S.P. and E.P. except for diameter 3-0 (2 metric), 18 Inches (45 cm) FDA UDI

Identifiers

Catalog Number
223125 FDA UDI
Primary DI / UDI-DI
10886705022939 FDA UDI
510(k) Number
K123668 FDA UDI
FDA Product Code
GAT FDA UDI
NEW FDA UDI
GMDN Term
Polyester suture, bioabsorbable, monofilament, non-antimicrobial FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
878.5000 FDA UDI
878.4840 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI
MRI Safety
MR Safe FDA UDI

Category: Polyester suture, bioabsorbable, monofilament, non-antimicrobial

Orthocord by Medos International Sàrl — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Polyester suture, bioabsorbable, monofilament, non-antimicrobial.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 0c40f259-3cfa-4bb4-a81f-b86a4cc2c077 36 fields · synced Jun 8, 2026